Climb Bio (CLYM) Interest Expenses (2020 - 2026)

Climb Bio's Interest Expenses history runs 7 years deep, the most recent figure standing at $32.4 million for Q1 2026.

• Quarterly Interest Expenses rose 5959.18% year-over-year to $32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.4 million (up 5959.18% YoY) and the FY2025 annual result came in at $11.7 million, down 58.84% from the prior year.
• Interest Expenses was $32.4 million for Q1 2026 at Climb Bio, up from $11.7 million in the prior quarter.
• Across five years, Interest Expenses topped out at $32.4 million in Q1 2026 and bottomed at $36000.0 in Q2 2025.
• A 5-year average of $7.0 million and a median of $2.4 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2024 — Interest Expenses tumbled 98.8% — and 2026, when it surged 5959.18%.
• Climb Bio's Interest Expenses stood at $16.8 million in 2022, then grew by 24.45% to $20.9 million in 2023, then plunged by 98.8% to $250000.0 in 2024, then soared by 4590.8% to $11.7 million in 2025, then surged by 175.91% to $32.4 million in 2026.
• Business Quant data shows CLYM's Interest Expenses at $32.4 million in Q1 2026, $11.7 million in Q4 2025, and $1.6 million in Q3 2025.